Jason R Kelly
CIK 1845677 · See remarks · last filed 2026-07-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
DNA.WS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
C/O CORVEX MANAGEMENT LP
NEW YORK, NY 10065
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNA | See remarks | 310,316 | $9.71 | $3.01M | -$1.37M | 2 | 2026-07-30 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | See remarks | 3,894,680 | $0.01 | $24.5K | -$43.84M | 92 | 2024-04-29 |
Recent Filings · Page 16 of 18
172 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-12-07 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −209,398 | -$377.1K | EDGAR |
| 2022-12-05 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −100,429 | -$198.0K | EDGAR |
| 2022-12-01 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −199,109 | -$367.2K | EDGAR |
| 2022-11-25 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −201,611 | -$407.0K | EDGAR |
| 2022-11-22 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −202,327 | -$431.8K | EDGAR |
| 2022-11-18 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −440,491 | -$992.9K | EDGAR |
| 2022-11-16 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −421,076 | -$1.10M | EDGAR |
| 2022-11-14 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −383,992 | -$983.0K | EDGAR |
| 2022-11-10 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −401,576 | -$981.1K | EDGAR |
| 2022-11-08 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −410,715 | -$1.01M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.